Trevi Therapeutics, Inc.
TRVI
$16.64
-$0.18-1.07%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 318.87M | 171.78M | 188.26M | 194.93M | 203.89M |
| Total Receivables | 1.60M | 1.10M | 986.00K | 1.20M | 834.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.26M | 2.22M | 1.26M | 1.38M | 1.77M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 972.00K | 1.02M | 1.15M | 794.00K | 743.00K |
| Total Current Assets | 325.71M | 176.12M | 191.66M | 198.30M | 207.23M |
|
|
|||||
| Total Current Assets | 325.71M | 176.12M | 191.66M | 198.30M | 207.23M |
| Net Property, Plant & Equipment | 878.00K | 875.00K | 855.00K | 954.00K | 1.04M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.94M | 2.61M | 928.00K | 103.00K | 68.00K |
| Total Assets | 330.52M | 179.61M | 193.44M | 199.36M | 208.34M |
|
|
|||||
| Total Accounts Payable | 3.10M | 2.22M | 3.91M | 2.71M | 2.97M |
| Total Accrued Expenses | 5.31M | 4.58M | 5.53M | 6.04M | 5.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 329.00K | 318.00K | 307.00K | 296.00K | 286.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.74M | 7.12M | 9.75M | 9.04M | 9.24M |
|
|
|||||
| Total Current Liabilities | 8.74M | 7.12M | 9.75M | 9.04M | 9.24M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 276.00K | 364.00K | 446.00K | 527.00K | 605.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.01M | 7.48M | 10.20M | 9.57M | 9.85M |
|
|
|||||
| Common Stock & APIC | 682.72M | 515.31M | 512.90M | 511.25M | 508.16M |
| Retained Earnings | -360.79M | -343.00M | -329.80M | -321.49M | -309.69M |
| Treasury Stock & Other | -425.00K | -190.00K | 148.00K | 30.00K | 24.00K |
| Total Common Equity | 321.51M | 172.13M | 183.24M | 189.79M | 198.49M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 321.51M | 172.13M | 183.24M | 189.79M | 198.49M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 321.51M | 172.13M | 183.24M | 189.79M | 198.49M |
|
|
|||||